Literature DB >> 11774323

Sterically blocking adhesion of cells to biological surfaces with a surface-active copolymer containing poly(ethylene glycol) and phenylboronic acid.

Natalie D Winblade1, Hugo Schmökel, Marion Baumann, Allan S Hoffman, Jeffrey A Hubbell.   

Abstract

Graft copolymers were designed that could spontaneously bind to biological surfaces and block subsequent recognition and adhesion at those surfaces. Phenylboronic acid (PBA) moieties in the polymer backbone provided binding to surfaces, forming reversible covalent complexes with cis-diols found in many biological molecules. Pendant poly(ethylene glycol) (PEG) side chains sterically protected those surfaces from subsequent interactions with other proteins and cells. The PEG and PBA grafting ratios on these poly-L-lysine-graft-(PEG;PBA) copolymers [PLL-g-(PEG;PBA)] were varied, and the polymers were tested in models relevant to undesirable wound-healing responses such as peritoneal adhesion formation and posterior capsule opacification. PLL-g-(PEG;PBA) polymers spontaneously coated tissue culture polystyrene and completely blocked rabbit lens epithelial cell adhesion to the surface over a wide range of PEG grafting ratios. PLL-g-(PEG;PBA)s with optimal grafting ratios were able to coat adsorbed serum proteins or extracellular matrices and block cell spreading on the surfaces at 4 h, although the effect was lost within 24 h. The polymer also enhanced the efficacy of surgical lysis of peritoneal adhesions in rats. The reversible covalent complexes formed by the PBA moieties on the copolymer backbone were more effective at binding biological surfaces than electrostatic interactions formed via a copolymer lacking the PBA moieties, that is, PLL-g-PEG. Copyright 2001 John Wiley & Sons, Inc. J Biomed Mater Res 59: 618-631, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774323     DOI: 10.1002/jbm.1273

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  8 in total

1.  Preparation and characterisation in simulated body conditions of glutaraldehyde crosslinked chitosan membranes.

Authors:  R M Silva; G A Silva; O P Coutinho; J F Mano; R L Reis
Journal:  J Mater Sci Mater Med       Date:  2004-10       Impact factor: 3.896

2.  Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry.

Authors:  Alamelu Mahalingam; Anthony R Geonnotti; Jan Balzarini; Patrick F Kiser
Journal:  Mol Pharm       Date:  2011-09-26       Impact factor: 4.939

3.  pH responsive self-healing hydrogels formed by boronate-catechol complexation.

Authors:  Lihong He; Dominic E Fullenkamp; José G Rivera; Phillip B Messersmith
Journal:  Chem Commun (Camb)       Date:  2011-06-01       Impact factor: 6.222

4.  Inhibition of Staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives.

Authors:  McKinley C Lawson; Kevin C Hoth; Cole A Deforest; Christopher N Bowman; Kristi S Anseth
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

5.  Use of phenylboronic acids to investigate boron function in plants. Possible role of boron in transvacuolar cytoplasmic strands and cell-to-wall adhesion.

Authors:  Elias Bassil; Hening Hu; Patrick H Brown
Journal:  Plant Physiol       Date:  2004-10-01       Impact factor: 8.340

6.  Facile coupling of synthetic peptides and peptide-polymer conjugates to cartilage via transglutaminase enzyme.

Authors:  Marsha Elizabeth Ritter Jones; Phillip B Messersmith
Journal:  Biomaterials       Date:  2007-09-17       Impact factor: 12.479

7.  A new microsphere-based immunoassay for measuring the activity of transcription factors.

Authors:  Yu-Ling Lin; Yun-Ju Lai; Tai-Chu Peng; Ru-Ping Lee; Kuang-Wen Liao; Nu-Man Tsai; Yen-Ku Liu; Chueh-Jen Tsai
Journal:  Biol Proced Online       Date:  2010-04-14       Impact factor: 3.244

8.  Insulin-loaded PLGA microspheres for glucose-responsive release.

Authors:  Jun-Zi Wu; Gareth R Williams; He-Yu Li; Dong-Xiu Wang; Shu-De Li; Li-Min Zhu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.